Significant association of SRC protein expression with the progression, recurrence, and prognosis of oral squamous cell carcinoma in Taiwan

Head and Neck

Volumn 34, Issue 9, 2012, Pages 1340-1345

  Cheng, Shih Jung ^a,b,c   Kok, Sang Heng ^b,c   Lee, Jang Jaer ^b,c   Yen Ping Kuo, Mark ^a,b,c   Cheng, Shih Lung ^d   Huang, Ying Luo ^a,c   Chen, Hsin Ming ^b,c   Chang, Hao Hueng ^a,b,c   Chiang, Chun Pin ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

cancer progression; oral cancer; prognosis; recurrence; Src protein

Indexed keywords

MEMBRANE PROTEIN; SRC PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; PROTEOMICS; RECURRENCE; SRC-FAMILY KINASES; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 84864981889     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21923     Document Type: Article

References (36)

1. Massano J, Regateiro FS, Januario G, Ferreira A,. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 67-76. (Pubitemid 44016111)
2. Cancer registry annual report in Taiwan area, 2010. Department of Health, The Executive Yuan, Taiwan, 2011.
3. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC,. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24: 450-453.
4. Kwan HW,. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formos Med Assoc 1976; 75: 497-505. (Pubitemid 8017857)
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
6. van Oijen MG, Rijksen G, ten Broek FW, Slootweg PJ,. Overexpression of c-Src in areas of hyperproliferation in head and neck cancer, premalignant lesions and benign mucosal disorders. J Oral Pathol Med 1998; 27: 147-152. (Pubitemid 28181101)
7. Lutz MP, Esser IB, Flossmann-Kast BB, et al. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun 1998; 243: 503-508. (Pubitemid 28414054)
8. Wilson GR, Cramer A, Welman A, et al. Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. Br J Cancer 2006; 95: 1410-1414. (Pubitemid 44760094)
9. Sun CK, Man K, Ng TK, et al. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis 2008; 29: 2096-2105.
10. Bertotti A, Bracco C, Girolami F, et al. Inhibition of Src impairs the growth of met-addicted gastric tumors. Clin Cancer Res 2010; 16: 3933-3943.
11. Sisci D, Aquila S, Middea E, et al. Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility. Oncogene 2004; 23: 8920-8930. (Pubitemid 39657782)
12. Franzen CA, Amargo E, Todorović V, et al. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Cancer Prev Res 2009; 2: 830-841.
13. Chen JY, Hung CC, Huang KL, et al. Src family kinases mediate betel quid-induced oral cancer cell motility and could be a biomarker for early invasion in oral squamous cell carcinoma. Neoplasia 2008; 10: 1393-1401.
14. Di Florio A, Capurso G, Milione M, et al. Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer 2007; 14: 111-124. (Pubitemid 47521727)
15. Mandal M, Myers JN, Lippman SM, et al. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 2008; 112: 2088-2100. (Pubitemid 351574086)
16. Peng L, Ran YL, Hu H, et al. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Carcinogenesis 2009; 30: 1660-1669.
17. Leung EL, Tam IY, Tin VP, et al. Src promotes survival and invasion of lung cancers with epidermal growth factor receptor abnormalities and is a potential candidate for molecular-targeted therapy. Mol Cancer Res 2009; 7: 923-932.
18. Summy JM, Gallick GE,. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 2003; 22: 337-358. (Pubitemid 36791891)
19. Lee JH, Pyon JK, Kim DW, et al. Elevated c-Src and c-Yes expression in malignant skin cancers. J Exp Clin Cancer Res 2010; 29: 116.
20. Michailidi C, Giaginis C, Stolakis V, et al. Evaluation of FAK and Src expression in human benign and malignant thyroid lesions. Pathol Oncol Res 2010; 16: 497-507.
21. Thalamonti MS, Roh MS, Curley SA, Gallick GE,. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest 1993; 91: 53-60. (Pubitemid 23037252)
22. Jacobs C, Rubsamen H,. Expression of pp60c-src protein kinase in adult and fetal human tissue: high activities in some sarcomas and mammary carcinomas. Cancer Res 1983; 43: 1696-1702. (Pubitemid 13122574)
23. Verbeek BS, Vroom TM, Adriaansen-Slot SS, et al. c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 1996; 180: 383-388. (Pubitemid 27014075)
24. Reissig D, Clement J, Sänger J, Berndt A, Kosmehl H, Böhmer FD,. Elevated activity and expression of Src-family kinases in human breast carcinoma tissue versus matched non-tumor tissue. Cancer Res Clin Oncol 2001; 127: 226-230.
25. Mazurenko NN, Kogan EA, Zborovskaya IB, Kisseljov FL,. Expression of pp60c-src in human small and non-small cell lung carcinomas. Eur J Cancer 1992; 28: 372-377.
26. Lau GM, Lau GM, Yu GL, et al. Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro. Dig Dis Sci 2009; 54: 1465-1474.
27. Myoui A, Nishimura R, Williams PJ, et al. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 2003; 63: 5028-5033. (Pubitemid 37022641)
28. Herynk MH, Zhang J, Parikh NU, Gallick GE,. Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells. J Exp Ther Oncol 2007; 6: 205-217. (Pubitemid 46789721)
29. Ischenko I, Guba M, Yezhelyev M, et al. Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Angiogenesis 2007; 10: 167-182. (Pubitemid 47305201)
30. Ischenko I, Seeliger H, Camaj P, et al. Src tyrosine kinase inhibition suppresses lymphangiogenesis in vitro and in vivo. Curr Cancer Drug Targets 2010; 10: 546-553.
31. Cartwright CA, Coad CA, Egbert BM,. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis J Clin Invest 1994; 93: 509-515. (Pubitemid 24072789)
32. Jeng JH, Wang YJ, Chiang BL, et al. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecolin. Carcinogenesis 2003; 24: 1301-1315.
33. Yamamoto T, Kimura T, Ueta E, Tatemoto Y, Osaki T,. Characteristic cytokine generation patterns in cancer cells and infiltrating lymphocytes in oral squamous cell carcinomas and the influence of chemoradiation combined with immunotherapy on these patterns. Oncology 2003; 64: 407-415. (Pubitemid 36682955)
34. Nakano Y, Kobayashi W, Sugai S, Kimura H, Yagihashi S,. Expression of tumor necrosis factor-alpha and interleukin-6 in oral squamous cell carcinoma. Jpn J Cancer Res 1999; 90: 858-866. (Pubitemid 29431365)
35. Younes F, Quartey EL, Kiguwa S, Partridge M,. Expression of TNF and the 55-kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma. Oral Dis 1996; 2: 25-31. (Pubitemid 126602146)
36. Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL,. Tumor necrosis factor-α mediates orthopedic implant osteolysis. Am J Pathol 1999; 154: 203-210. (Pubitemid 29031627)